2022 Archive

Dr. James R. Downing details how St. Jude strategic plan expansion aims to accelerate research and treatment for childhood catastrophic diseases.

Stimulating the adaptive immune response can improve outcomes for ALL treated with chemotherapy.

St. Jude research has advanced understanding of the immune response to SARS-CoV-2 infection and vaccination. Here is what the findings mean for you.

HPV vaccination rates dipped during the COVID-19 pandemic. St. Jude is working with more than 100 organizations, health experts and others to highlight vaccination as cancer prevention.

What lessons can be learned from the remarkable success of SAFER Ukraine?

Muscle signaling provide clues for treatment of the muscle-wasting disorder cachexia, which affects cancer patients.

Interim results point to enduring immune function following gene therapy for Infants with ‘bubble boy’ disease

May is Brain Tumor Awareness Month and a good time to learn more about the diverse group of diseases that make up the most common childhood solid tumor.

“SAFER Ukraine works because we have human connections with our partners,” explains Asya Agulnik, MD, MPH.

Marcin Wlodarski, MD, PhD, was new to international humanitarian work prior to volunteering with SAFER Ukraine. “I learned so much I cannot every describe it in words,” he said.